Jasper Therapeutics, Inc. - 8-K Filing

Jasper Therapeutics filed audited financial statements for Kira Pharmaceuticals showing a $4.37B net loss for the year ended December 31, 2025.

SEC EDGAR ·

Tickers: $JSPR

Read the full article at SEC EDGAR

More Regulatory news